PLN‐1561

N/A

Report date: 2023/03/05 18:10:16
NME

Base Information

Drug NamePLN‐1561
Drug Alias NamePLN‐1561
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-6 antagonistsIntegrin alpha-V/beta-1 inhibitors
TargetsIntegrin alpha-V/beta-6Integrin alpha-V/beta-1
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A